Jacob Haase

6PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersSolid tumoursRegenerative medicine (incl. stem cells)Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 21, 2023
Telomerase Upregulation Induces Progression of Mouse BrafV600E-Driven Thyroid Cancers and Triggers Nontelomeric Effects.

Iñigo Landa, Caitlin E M Thornton, Bin Xu

|Jun 01, 2023
Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes.

Athanasios Bikas, Sara Ahmadi, Theodora Pappa

|Dec 10, 2021
MiRNA Deregulation Distinguishes Anaplastic Thyroid Carcinoma (ATC) and Supports Upregulation of Oncogene Expression.

Danny Misiak, Marcus Bauer, Jana Lange

|Dec 09, 2020
MSI1 Promotes the Expression of the GBM Stem Cell Marker CD44 by Impairing miRNA-Dependent Degradation.

Rebecca Pötschke, Jacob Haase, Markus Glaß

|Jul 29, 2020
IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis.

Jacob Haase, Danny Misiak, Marcus Bauer

|Mar 22, 2019
The Critical Role of RNA m6A Methylation in Cancer.

Qing Lan, Pei Y Liu, Jacob Haase

Pageof 1

Frequent Collaborators

2 joint publications

Danny Misiak

2 joint publications

Iñigo Landa

1 joint publications

Jessica L Bell

1 joint publications

Markus Glaß